Skip to content

Skin & hair

SNAP-8

Acetyl Octapeptide-3 · Acetyl Glutamyl Heptapeptide-1

Early human trialsReviewed 18 Aug 2026

SNAP-8 is Argireline with one more amino acid: an eight-residue version of the same idea, mimicking a segment of SNAP-25 to interfere with the protein complex that releases acetylcholine at the neuromuscular junction.

The marketing claim is that the longer peptide binds more effectively and so reduces expression wrinkles more than Argireline does. Manufacturer-sponsored comparisons report exactly that. Independent comparisons are scarce.

It also inherits Argireline's central problem and makes it slightly worse. At roughly 1 kDa it is even further above the size that passes readily through intact skin, so however well it performs in an assay, the amount reaching a facial muscle is the unresolved question.

How it works

SNAP-8 mimics a segment of SNAP-25, one of the SNARE proteins that pull a neurotransmitter vesicle into contact with the cell membrane. Competing for a place in that complex makes it assemble less efficiently, so less acetylcholine is released and the muscle contracts slightly less.

Botulinum toxin acts on the same protein by cleaving it enzymatically, destroying it instead of competing with it. That is a difference of kind, not degree, and it is why the effects are not comparable.

The eight-residue length is the claimed advantage over Argireline's six. It is also more mass to move through the stratum corneum, which is the barrier that limits both.

Regulatory status — United States

Sold as a cosmetic ingredient, not a drug, in the United States, the European Union and elsewhere. Cosmetics are not assessed for efficacy before sale, and claims must stay within cosmetic language. That is why products describe the appearance of wrinkles instead of treating them.

Last reviewed 18 Aug 2026. Regulatory positions in this category change frequently; we date this line so you can see how current it is.

What it is studied for

Each entry states the evidence behind it. We do not rank indications by effectiveness — for most compounds here, that would be a claim nobody can support.

Reducing the appearance of expression wrinkles

Manufacturer

The cosmetic use.

EvidenceManufacturer-sponsored studies report reductions in wrinkle depth, and describe it as outperforming Argireline. Independent comparisons are scarce.

Identity and clearance

Molecule

Class
Acetylated octapeptide, SNAP-25 mimetic
Molecular weight
1075.1 Da
Length
8 amino acids

An extended analogue of acetyl hexapeptide-8 (Argireline), and further above the rough 500-dalton threshold for easy skin penetration.

Dose protocols reported in sources

Displayed for reference only. Every row says where it came from, and a trial protocol and a community convention are not the same kind of information. None of this is fed into the calculator, and none of it is a recommendation.

Dose protocols reported in sources, with the source of each.
GoalDoseFrequencyRouteUnitsSourceStart this protocol
Concentration used in cosmetic formulations25 mg – 50 mgApplied twice dailyTopicalTypically formulated at around 5% to 10%. The figures are the peptide content of a single application at those concentrations. They are not a dose in the sense used elsewhere on this site, because almost none of it crosses the skin.ManufacturerStart this

Start this copies a row into a protocol of your own, which you can then edit. Where a source gave a dose range or an ambiguous frequency, those fields arrive empty — we will not pick a number on your behalf.

Safety

Reported effects

  • Mild skin irritation or rednessManufacturer

    Uncommon

    Usually attributable to other ingredients in the formulation.

  • Contact dermatitisManufacturer

    Rare

  • Systemic effectsManufacturer

    Not expected

    Meaningful systemic absorption through intact skin is unlikely at this size. The same barrier that limits the cosmetic effect limits the risk.

When to stop

  • Persistent redness, itching or burning where it is applied.
  • Any rash spreading beyond the application area.
  • Swelling of the eyelids or around the eyes.
  • Any sign the product has spoiled.

Interactions and situations that need care

  • Broken, irritated or freshly treated skinUse caution

    Applying anything to compromised skin bypasses the barrier that normally limits both absorption and irritation, which changes the risk from negligible to unpredictable.

  • Application close to the eyeUse caution

    Crow's feet are the target and the eye is next to them. Cosmetic serums are not formulated as ophthalmic products, and a contaminated home mix makes this more than theoretical.

  • Pregnancy and breastfeedingUnknown

    No specific safety data exists. Systemic absorption is expected to be minimal. That is a reason for reassurance, not a study. Nobody has looked.

  • Mixing your own serum from raw powderUse caution

    A finished cosmetic contains a preservative system for a reason. A home mix has none, will grow bacteria within weeks, and is applied beside your eyes.

What to expect

  • The claim that it beats Argireline comes largely from manufacturer-sponsored work. Independent comparisons are scarce.
  • It is not comparable to botulinum toxin. Same target protein, entirely different mechanism and magnitude.
  • It is larger than Argireline, so the penetration problem is if anything slightly worse.
  • The formulation matters more than the percentage on the label.
  • Among the lowest-risk compounds on this site. Nothing is injected, and the main hazard is a home mix going bad.

Storage and handling

Freeze-dried powder
Finished serums at room temperature, out of direct sunlight. Raw peptide powder is best refrigerated.
After mixing
A finished cosmetic has a preservative system and typically lasts 6 to 12 months after opening. A home mix has none and will grow bacteria within weeks, near your eyes.

Printable one-pagerHow to reconstitute a vial, step by step

With other peptides

  • Argirelinecaution

    Both mimic the same SNAP-25 segment. Using both means competing for the same site twice rather than covering two mechanisms, and neither has independent evidence of a large effect.

Check this against a whole stack

Checking your vial

Research chemicals carry no manufacturing standard, so what the vial looks like is often the only quality signal available before you use it. More on assessing quality and COAs.

  • Clear or lightly tinted serum, consistent in texture

    Normal for a finished cosmetic formulation.

  • Separation, colour change, or any smell

    The preservative system has failed. Discard it rather than applying it near your eyes.

  • The percentage on the label is not the whole story

    Whether the peptide penetrates depends on the formulation around it. A high concentration in a vehicle that does not deliver it is a number, not an effect.

Questions

Is it better than Argireline?
That is the claim, and it comes mostly from manufacturer-sponsored comparisons. It is also a larger molecule, which makes getting through the skin harder rather than easier.
Is it like Botox?
Same target protein, completely different mechanism. Botulinum toxin is injected into the muscle and enzymatically destroys SNAP-25; this sits on the skin surface and competes with it weakly, if it gets through at all.

References

  1. Acetyl octapeptide-3 in topical anti-wrinkle formulations: manufacturer efficacy studies

    Cosmetic science literature and manufacturer documentation, 2012 · Cosmetic efficacy studies, largely manufacturer-sponsored

    Adult volunteers with periorbital expression lines · 5% to 10% formulations applied twice daily

    Reported reductions in wrinkle depth, described as exceeding those of acetyl hexapeptide-8. Independent replication is scarce, and penetration through intact skin remains the limiting factor for any peptide of this size.

Keep this page honest

If something here is wrong, out of date, or missing a source, tell us and we will fix it and say that we did.

Suggest a correction

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice. No clinician reviews these pages.

Page last updated 18 Aug 2026